These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Diagnosis and treatment of spastic angina revealed by cardiac arrest]. Halna du Fretay X; Mohammed Saeed D; Benamer H Ann Cardiol Angeiol (Paris); 2014 Dec; 63(6):465-70. PubMed ID: 25450997 [TBL] [Abstract][Full Text] [Related]
43. The efficacy of amlodipine in the management of ischaemic heart disease. McGibney D Postgrad Med J; 1991; 67 Suppl 3():S24-8. PubMed ID: 1836871 [TBL] [Abstract][Full Text] [Related]
44. Abnormal heart rate control in vasospastic angina: effects of calcium antagonists. Sato I; Hasegawa Y; Funahashi T; Tomobuchi Y; Ohe T; Haze K; Shimomura K Int J Cardiol; 1985 Jul; 8(3):313-25. PubMed ID: 4018917 [TBL] [Abstract][Full Text] [Related]
45. [Calcium inhibitors and myocardial ischemia]. Thuillez C Therapie; 1993; 48 Spec No():671-6. PubMed ID: 8091353 [TBL] [Abstract][Full Text] [Related]
46. Amlodipine versus diltiazem CR in the reduction of the total ischemic burden: the Circadian Anti-Ischemia Program in Europe (CAPE) II trial--clinical rationale and methodology. Deanfield JE Cardiovasc Drugs Ther; 1998 Oct; 12 Suppl 3():239-42. PubMed ID: 9800053 [TBL] [Abstract][Full Text] [Related]
47. Myocardial infarction with non-obstructive coronary arteries: a focus on vasospastic angina. Beijk MA; Vlastra WV; Delewi R; van de Hoef TP; Boekholdt SM; Sjauw KD; Piek JJ Neth Heart J; 2019 May; 27(5):237-245. PubMed ID: 30689112 [TBL] [Abstract][Full Text] [Related]
48. Microvascular coronary artery spasm presents distinctive clinical features with endothelial dysfunction as nonobstructive coronary artery disease. Ohba K; Sugiyama S; Sumida H; Nozaki T; Matsubara J; Matsuzawa Y; Konishi M; Akiyama E; Kurokawa H; Maeda H; Sugamura K; Nagayoshi Y; Morihisa K; Sakamoto K; Tsujita K; Yamamoto E; Yamamuro M; Kojima S; Kaikita K; Tayama S; Hokimoto S; Matsui K; Sakamoto T; Ogawa H J Am Heart Assoc; 2012 Oct; 1(5):e002485. PubMed ID: 23316292 [TBL] [Abstract][Full Text] [Related]
49. Effects of calcium antagonists, especially nifedipine, on variant angina, resting angina, and unstable angina. Kishida H; Otsu F; Kusama Y; Takayama M; Hayakawa H; Kimura E Jpn Heart J; 1982 Nov; 23(6):871-81. PubMed ID: 7161875 [TBL] [Abstract][Full Text] [Related]
50. Calcium channel blocking agents and the heart. Kenny J Br Med J (Clin Res Ed); 1985 Oct; 291(6503):1150-2. PubMed ID: 3931832 [No Abstract] [Full Text] [Related]
51. Beneficial effects of exercise training on physical performance in patients with vasospastic angina. Sugisawa J; Matsumoto Y; Takeuchi M; Suda A; Tsuchiya S; Ohyama K; Nishimiya K; Akizuki M; Sato K; Ohura S; Ota H; Ikeda S; Shindo T; Kikuchi Y; Hao K; Shiroto T; Takahashi J; Miyata S; Sakata Y; Takase K; Kohzuki M; Shimokawa H Int J Cardiol; 2021 Apr; 328():14-21. PubMed ID: 33309635 [TBL] [Abstract][Full Text] [Related]
52. Efficacy of Diltiazem to Improve Coronary Vasomotor Dysfunction in ANOCA: The EDIT-CMD Randomized Clinical Trial. Jansen TPJ; Konst RE; de Vos A; Paradies V; Teerenstra S; van den Oord SCH; Dimitriu-Leen A; Maas AHEM; Smits PC; Damman P; van Royen N; Elias-Smale SE JACC Cardiovasc Imaging; 2022 Aug; 15(8):1473-1484. PubMed ID: 35466050 [TBL] [Abstract][Full Text] [Related]
53. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial. Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA; JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593 [TBL] [Abstract][Full Text] [Related]
55. Ultra-long acting calcium channel blockers may decrease accuracy of the acetylcholine provocation test. Kurabayashi M; Asano M; Shimura T; Suzuki H; Aoyagi H; Yamauchi Y; Okishige K; Ashikaga T; Isobe M Int J Cardiol; 2017 Jun; 236():71-75. PubMed ID: 28268085 [TBL] [Abstract][Full Text] [Related]
56. Clinical outcome after treatment of rest angina with calcium blockers: comparative experience during the initial year of therapy with diltiazem, nifedipine, and verapamil. Pepine CJ; Feldman RL; Hill JA; Conti CR; Mehta J; Hill C; Scott E Am Heart J; 1983 Dec; 106(6):1341-7. PubMed ID: 6359845 [TBL] [Abstract][Full Text] [Related]
57. Calcium-channel blockers and beta blockers: advantages and disadvantages of combination therapy in chronic stable angina pectoris. Krikler DM; Harris L; Rowland E Am Heart J; 1982 Sep; 104(3):702-8. PubMed ID: 6126115 [TBL] [Abstract][Full Text] [Related]
58. [The anti-anginal effect of diltiazem in patients with stable exercise-induced stenocardia and vasospastic stenocardia compared with the effect of nifedipine]. Kocherga EIu; Glukhovtsev EV; Gratsianskiĭ NA Kardiologiia; 1990 Feb; 30(2):29-31. PubMed ID: 2190040 [TBL] [Abstract][Full Text] [Related]
59. Clinical use of calcium entry blockers. Flaim SF; Zelis R Fed Proc; 1981 Dec; 40(14):2877-81. PubMed ID: 7308498 [TBL] [Abstract][Full Text] [Related]
60. Tortuous diagnosis and treatment of a patient with coronary vasospastic angina(VSA). Yao YY; Zhang LL; Zhao LX; Luo DL Asian J Surg; 2023 Mar; 46(3):1524-1525. PubMed ID: 36202704 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]